Finance

Lists
524703:BOM
Sandu Pharmaceuticals Ltd
35,66 ₹
+1,60%
(+0,56) 1D
16 қаз., 15:52:26 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524703...
Open
35,49 ₹
High
36,39 ₹
Low
35,49 ₹
Mkt. cap
344,51 млн
Avg. vol.
2,20 мың
Volume
1,24 мың
Dividend
2,80%
Quarterly dividend
0,25 ₹
Ex-dividend date
2026 ж. 04 қыр.
P/E ratio
18,15
52-wk high
50,00 ₹
52-wk low
30,00 ₹
EPS
1,97 ₹
No. of employees
258
Open
35,49 ₹
High
36,39 ₹
Low
35,49 ₹
Mkt. cap
344,51 млн
Avg. vol.
2,20 мың
Volume
1,24 мың
Dividend
2,80%
Quarterly dividend
0,25 ₹
Ex-dividend date
2026 ж. 04 қыр.
P/E ratio
18,15
52-wk high
50,00 ₹
52-wk low
30,00 ₹
EPS
1,97 ₹
No. of employees
258
News stories
From web sources and news partners
About Sandu Pharmaceuticals Ltd
CEO-
Employees258
Founded1899
Headquarters-
SectorPersonal care products
Websitesandu.in
Last report
2026 ж. 11 там.
Fiscal period
Q1 2027
- / -
Revenue / Est. (INR)
163,89 млн / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
176,21 млн
187,61 млн
168,53 млн
163,89 млн
Cost of goods sold
83,27 млн
78,87 млн
85,77 млн
65,40 млн
Cost of revenue
83,27 млн
78,87 млн
85,77 млн
65,40 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
26,38 млн
26,46 млн
122,83 млн
27,94 млн
Operating expense
86,01 млн
99,99 млн
78,68 млн
94,76 млн
Total operating expenses
169,28 млн
178,86 млн
164,46 млн
160,16 млн
Operating income
6,93 млн
8,75 млн
4,08 млн
3,73 млн
Other non operating income
480,00 м.
137,00 м.
-837,00 м.
174,00 м.
EBT including unusual items
7,15 млн
8,55 млн
7,47 млн
3,60 млн
EBT excluding unusual items
7,15 млн
8,55 млн
7,47 млн
3,60 млн
Income tax expense
1,90 млн
-1,20 млн
7,04 млн
1,32 млн
Effective tax rate
26,63%
-14,05%
94,18%
36,70%
Other operating expenses
57,94 млн
71,87 млн
-45,80 млн
65,18 млн
Net income
5,24 млн
9,75 млн
435,00 м.
2,28 млн
Net profit margin
2,98%
5,20%
0,26%
1,39%
Earnings per share
-
-
-
-
Interest and investment income
-
-
4,44 млн
-
Interest expense
-266,00 м.
-335,00 м.
-212,00 м.
-299,00 м.
Net interest expenses
-266,00 м.
-335,00 м.
4,23 млн
-299,00 м.
Depreciation and amortization charges
1,69 млн
1,66 млн
1,65 млн
1,64 млн
EBITDA
8,66 млн
9,86 млн
5,18 млн
5,42 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары